LAVA Medtech Acquisition Corp.’s (NASDAQ:LVACU) Lock-Up Period Set To End on April 25th

LAVA Medtech Acquisition’s (NASDAQ:LVACUGet Rating) lock-up period will expire on Monday, April 25th. LAVA Medtech Acquisition had issued 10,000,000 shares in its IPO on October 27th. The total size of the offering was $100,000,000 based on an initial share price of $10.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Shares of LAVA Medtech Acquisition stock opened at $10.04 on Monday. LAVA Medtech Acquisition has a 12 month low of $9.89 and a 12 month high of $10.20. The business’s fifty day simple moving average is $10.10.

Institutional investors have recently modified their holdings of the stock. Sage Mountain Advisors LLC acquired a new stake in LAVA Medtech Acquisition during the 4th quarter worth $175,000. Alliancebernstein L.P. acquired a new stake in LAVA Medtech Acquisition during the 4th quarter worth $248,000. LMR Partners LLP acquired a new stake in LAVA Medtech Acquisition during the 4th quarter worth $252,000. Calamos Advisors LLC bought a new position in LAVA Medtech Acquisition during the 4th quarter worth about $262,000. Finally, Glazer Capital LLC bought a new position in LAVA Medtech Acquisition during the 4th quarter worth about $323,000.

LAVA Medtech Acquisition Company Profile (Get Rating)

LAVA Medtech Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. It focuses on pursuing opportunities in healthcare and healthcare-related industries primarily in the United States and Canada. The company was incorporated in 2021 and is based in Waltham, Massachusetts.

Featured Stories

Receive News & Ratings for LAVA Medtech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LAVA Medtech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.